Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: A decision analysis study
- Tan N. Doan*
- , Greg J. Fox
- , Michael T. Meehan
- , Nick Scott
- , Romain Ragonnet
- , Kerri Viney
- , James M. Trauer
- , Emma S. McBryde
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
35
Citations
(Scopus)